@article{TCR10449,
author = {Chiara Ciccarese and Giampaolo Tortora and Rodolfo Montironi and Francesco Massari},
title = {Is there still an open window in metastatic castration resistant prostate cancer immunotherapy horizon?},
journal = {Translational Cancer Research},
volume = {5},
number = {Suppl 6},
year = {2016},
keywords = {},
abstract = {In recent years, immunotherapy (mainly with immune checkpoint inhibitors directed against CTLA-4 or the PD-1/PD-L1 axis) represents the breakthrough of anticancer therapy for several highly immunogenic tumors (melanoma, non-small cell lung cancer, and renal cell carcinoma).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/10449}
}